Variables | Conventional | Restrictive |
---|---|---|
Therapeutic intervention | ||
Intraoperative | ||
Operation time, minutes | 228 ± 53 | 250 ± 60 |
Crystalloid, ml | 4, 335 ± 1, 546 | 2, 301 ± 1, 064** |
Colloid, ml | 915 ± 559 | 1, 216 ± 814* |
Fluid-challenged patients | 42 (97.7) | 44 (97.7) |
Fluid challenges per patient | 2.4 | 3.1 |
Positive fluid challenges | 61 (58.6) | 93 (65.0) |
Transfused patients (RBCs) | 18 (41.8) | 19 (42.2) |
RBCs, units | 1.8 ± 0.4 | 1.9 ± 0.9 |
Dobutamine doses, μg/kg/minute | 12.3 ± 7.3 | 10.9 ± 5.9 |
Achievers | 26 (60.4) | 18 (40.0) |
Postoperative | ||
Crystalloid, ml | 1, 296 ± 1114 | 1, 145 ± 680 |
Colloid, ml | 1, 321 ± 595 | 1, 210 ± 700 |
RBC transfusions | 10 (23.2) | 11 (24.4) |
RBCs, units | 1.7 ± 0.7 | 1.5 ± 0.5 |
Dobutamine dose, μg/kg/minute | 9.5 ± 6.2 | 8.0 ± 4.5 |
Tissue perfusion | ||
Preoperative | ||
Serum lactate, mEq/L | 1.3 ± 0.4 | 1.3 ± 0.5 |
SCVO2, % | 72 ± 7 | 71 ± 7 |
pH | 7.39 ± 0.05 | 7.41 ± 0.04 |
ICU admission | ||
Serum lactate, mEq/L | 2.51 ± 1.1 | 2.6 ± 1.2 |
SCVO2, % | 72 ± 10 | 74 ± 10 |
pH | 7.32 ± 0.06 | 7.32 ± 0.07 |
24 hours after ICU admission | ||
Serum lactate, mEq/L | 1.9 ± 0.8 | 2.0 ± 0.9 |
SCVO2, % | 76 ± 8 | 72 ± 9* |
pH | 7.39 ± 0.05 | 7.3 5 ± 0.05 |
Achievers | 31 (73.0) | 28 (62.2) |